FibroGen, Inc. (FGEN)
NASDAQ: FGEN · Real-Time Price · USD
0.706
-0.067 (-8.61%)
At close: Feb 21, 2025, 4:00 PM
0.658
-0.048 (-6.80%)
After-hours: Feb 21, 2025, 7:59 PM EST

FibroGen Stock Forecast

FGEN's stock price has decreased by -60.78% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for FibroGen stock has a target of 10, which predicts an increase of 1,316.63% from the current stock price of 0.71.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $10 $10 $10 $10
Change +1316.6% +1316.6% +1316.6% +1316.6%

Analyst Ratings

According to 1 stock analyst, the rating for FibroGen is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Sep '24Oct '24Nov '24Dec '24Jan '25Feb '25
Strong Buy 000001
Buy 000000
Hold 444440
Sell 111110
Strong Sell 111110
Total 666661

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$10
Strong Buy Reiterates $10 +1,316.63% Feb 20, 2025
B of A Securities
B of A Securities
Sell
Downgrades
$4$2
Sell Downgrades $4$2 +183.33% Aug 8, 2023
Goldman Sachs
Goldman Sachs
Strong Sell
Maintains
$16$2
Strong Sell Maintains $16$2 +183.33% Jun 27, 2023
Raymond James
Raymond James
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Jun 27, 2023
B of A Securities
B of A Securities
Hold
Downgrades
$29$4
Hold Downgrades $29$4 +466.65% Jun 26, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
180.13M
from 147.75M
Increased by 21.91%
Revenue Next Year
168.31M
from 180.13M
Decreased by -6.56%
EPS This Year
-0.82
from -2.92
EPS Next Year
-0.46
from -0.82
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
256.58M176.32M235.31M140.73M147.75M180.13M168.31M180.81M
Revenue Growth
20.48%-31.28%33.46%-40.19%4.99%21.91%-6.56%7.43%
EPS
-0.89-2.11-3.14-3.14-2.92-0.82-0.46-0.39
EPS Growth
--------
Forward PE
--------
No. Analysts -----444
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 2024202520262028
High 185.8M 194.3M 213.7M
Avg 180.1M 168.3M 180.8M
Low 172.7M 142.1M 148.0M

Revenue Growth

Revenue Growth 2024202520262028
High
25.8%
7.8%
27.0%
Avg
21.9%
-6.6%
7.4%
Low
16.9%
-21.1%
-12.1%

EPS Forecast

EPS 202420252026
High -0.78 -0.40 -0.21
Avg -0.82 -0.46 -0.39
Low -0.84 -0.52 -0.55

EPS Growth

EPS Growth 202420252026
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.